Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
This finding suggests that overall rates of use in the population have held steady over the past two years
Artif Cells Nanomed Biotechnol 46:10091017
HR-ESI (positive ion mode): 620.0349 m/z [M] +
In the late 2000s, gemcitabine + cisplatin became the standard chemotherapy regimen for bladder cancer, compared with the traditional MVAC regimen (methotrexate + vinblastine + doxorubicin + cisplatin), it has lower toxicity and similar efficacy (Xia et al., 2022)
View AAPP's Copyright Statement, Terms of Use, and Policies AAPP owns the copyright, is licensed or has received permissions for use of, or is otherwise permitted to use copyrighted materials within any CPE activity
